NEPHROLOGY AND HYPERTENSION ASSOCIATES Revenue and Competitors
Estimated Revenue & Valuation
- NEPHROLOGY AND HYPERTENSION ASSOCIATES's estimated annual revenue is currently $28.6M per year.
- NEPHROLOGY AND HYPERTENSION ASSOCIATES's estimated revenue per employee is $270,000
Employee Data
- NEPHROLOGY AND HYPERTENSION ASSOCIATES has 106 Employees.
- NEPHROLOGY AND HYPERTENSION ASSOCIATES grew their employee count by 13% last year.
NEPHROLOGY AND HYPERTENSION ASSOCIATES's People
Name | Title | Email/Phone |
---|
NEPHROLOGY AND HYPERTENSION ASSOCIATES Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $6.7M | 31 | 7% | N/A | N/A |
#2 | $8.4M | 39 | -9% | N/A | N/A |
#3 | $17M | 70 | 4% | N/A | N/A |
#4 | $8M | 37 | 12% | N/A | N/A |
#5 | $63.3M | 213 | 7% | N/A | N/A |
#6 | $5.1M | 27 | 4% | N/A | N/A |
#7 | $23.2M | 86 | 5% | N/A | N/A |
#8 | $3.8M | 20 | -41% | N/A | N/A |
#9 | $6.9M | 32 | -9% | N/A | N/A |
#10 | $4M | 21 | -16% | N/A | N/A |
What Is NEPHROLOGY AND HYPERTENSION ASSOCIATES?
Certified Hypertension Center by the American Society of Hypertension Specialist in Kidney Disease and Hypertension We provide collaborative and companionate care for patient with kidney disease and hypertension. Multidisciplinary teams care for patients with End stage kidney disease offering all dialysis modalities including: hemodialysis, home hemodialysis and peritoneal dialysis and home nocturnal hemodialysis. Per and post renal transplant care. Collaborative care for patients with chronic kidney disease focusing on slowing disease progression and planned transitions of care. Providing excellence in care to patients and families.
keywords:N/AN/A
Total Funding
106
Number of Employees
$28.6M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $26M | 106 | 1% | N/A |
#2 | $7.5M | 108 | 16% | N/A |
#3 | $19.8M | 110 | 10% | N/A |
#4 | $7.5M | 111 | 23% | N/A |
#5 | $7.5M | 122 | 1% | N/A |